© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, The Beauty Health Company (SKIN) shows an Average True Range (ATR) of 0.08 and an Enterprise Value of 618.06M. Its average trading volume over the past 3 months is 681.04K, indicating liquidity. These fundamental metrics provide insight into SKIN's underlying financial health and market activity.
| ATR | 0.08 |
| Enterprise Value | 618.06M |
| Avg Vol (3 Months) | 681.04K |
| Avg Vol (10 Days) | 697.01K |
The Beauty Health Company (SKIN) technical indicators as of April 21, 2026: the SMA 20 is -15.58%, SMA 50 at -28.02%, and SMA 200 at -40.93%. The RSI 14 value is 29.98, suggesting its current momentum. These technical analysis signals help assess SKIN's price trends and potential future movements.
| SMA 20 | -15.58% |
| SMA 50 | -28.02% |
| SMA 200 | -40.93% |
| RSI 14 | 29.98 |
The Beauty Health Company (SKIN) stock performance overview as of April 21, 2026: The 52-week high is $2.69 (currently -63.87% below), and the 52-week low is $0.757 (currently 24.62% above). Over the past year, SKIN's performance is -11.11%, compared to the S&P 500's 25.03% change.
| 52-Week High | 2.69 |
| 52-Week High Chg | -63.87% |
| 52-Week Low | 0.75725 |
| 52-Week Low Chg | +24.62% |
| S&P 500 52-Week Chg | 25.03% |
According to market data, The Beauty Health Company (SKIN) stock's recent performance metrics show that over the last month, SKIN is -4%, with a Year-to-Date (YTD) performance of 3.6%. Over the past year, the stock has seen a -11.11% change. These figures summarize SKIN's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 1 | 1.22 | 1.65 | 1.74 | 2.69 | 1.65 |
| Low | 0.8562 | 0.75725 | 0.75725 | 0.75725 | 0.75725 | 0.75725 |
| Performance | -4.64% | -4.00% | +0.70% | -13.25% | -11.11% | +3.60% |
According to current financial data, SKIN stock's P/E (TTM) ratio is -11.91, which compares to the S&P 500's P/E of 32.59. The sector median P/E is 8.34. Key valuation ratios for SKIN, including P/S (0.38), P/B (1.85), and P/FCF (3.13), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | SKIN | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -11.91 | 8.34 | 42.72 | 32.59 |
| P/S (TTM) | 0.38 | 0.93 | 3.59 | 5.98 |
| P/B (TTM) | 1.85 | 1.23 | 37.88 | 4.94 |
| P/FCF (TTM) | 3.13 | 6.68 | -44.85 | 34.29 |